HOME >> BIOLOGY >> NEWS
Millennium's LDP(PS)-341 inhibits growth and induces death of cancer cells, appears to overcome chemotherapy resistance

LDP-341 Press release and fact sheet on multiple myeloma:

-Clinical and preclinical data presented at American Society for Hematology Meeting-

-Additional clinical trials planned with National Cancer Institute -

San Francisco, Dec. 4, 2000 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced the presentation of preclinical and clinical study results demonstrating that an investigational proteasome inhibitor, LDP-341 (formerly PS-341), the first in a new class of anti-cancer agents, is active against multiple myeloma. The latest findings were presented at the 42nd Annual Meeting of the American Society of Hematology (ASH) meeting in San Francisco.

The first presentation, entitled "The Proteasome Inhibitor PS-341 Inhibits Growth, Induces Apoptosis and Overcomes Drug Resistance in Human Multiple Myeloma (MM) Cells," was based on research conducted by Teru Hideshima, M.D., Ph.D., and colleagues at Dana-Farber Cancer Institute and Harvard Medical School in collaboration with Millennium. In the preclinical study, LDP-341, a proprietary small molecule compound, showed in vitro activity against multiple myeloma cells, resulting in the inhibition of cancer cell growth and reproduction, and the inducement of cell suicide (apoptosis), in animals. The potent anti-tumor action of LDP-341 on multiple myeloma cells in these preclinical studies appears to involve both direct (apoptosis) and indirect inhibition of growth factors that promote tumor growth. In addition, in animals LDP-341 appears to increase the effectiveness of other anti-cancer drugs by overcoming cellular resistance, which in humans is a major cause of chemotherapy failure.

Clinical research was presented at the meeting by Thomas Stinchcombe, M.D., and principal investigator Robert Orlowski, M.D., Ph.D., in a report entitled "PS-341 is Active in Multiple Myeloma: Preliminary Report of a Phase I Trial of the Proteasome
'"/>

Contact: Lynn Smiledge, Millennium
617-761-4700
Porter Novelli
4-Dec-2000


Page: 1 2 3 4 5 6

Related biology news :

1. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
2. The amendment to the law on green Genetic Engineering inhibits innovation and research in Germany
3. Inhibition of cathepsin proteases inhibits tumor formation in transgenic mice
4. Obesity drug inhibits prostate tumor growth
5. Protein inhibits cell growth, may contribute to breast cancer
6. ENBREL combo therapy inhibits joint damage progression, offers significant RA symptom relief
7. Aspirin inhibits ovarian cancer growth, lab study finds
8. UIC chemists identify compound that inhibits cell migration
9. UT Southwestern researchers find protein that both instigates, inhibits heart growth in mice
10. Bile acid inhibits cell death in Huntingtons disease
11. Researchers explain how protein inhibits angiogenesis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/23/2017)... 23, 2017 The report "Gesture Recognition and Touchless Sensing ... Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is expected ... 29.63% between 2017 and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... March 21, 2017 Optimove , ... by retailers such as 1-800-Flowers and AdoreMe, today ... Recommendations and Replenishment. Using Optimove,s machine learning algorithms, ... product and replenishment recommendations to their customers based ... predictions of customer intent drawn from a complex ...
Breaking Biology News(10 mins):
(Date:8/15/2017)... ... August 15, 2017 , ... Kenall, ... modular downlights designed to stay tightly sealed and perform efficiently for years. The ... wet location listings just aren't enough, such as: hospitals; behavioral health facilities; cleanrooms; ...
(Date:8/14/2017)... Portland, Oregon (PRWEB) , ... August 14, 2017 ... ... modules that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... hardware. , SYZYGY is intended to satisfy the need for a compact, low ...
(Date:8/11/2017)... Wauwatosa, WI (PRWEB) , ... August 11, 2017 ... ... transparency in food production, and, in particular, more natural alternatives to synthetic ingredients,” ... and innovation of Third Wave, with the established manufacturing presence and know-how of ...
(Date:8/10/2017)... ... August 09, 2017 , ... Okyanos Center for Regenerative Medicine ... the Pelican Bay Hotel in Freeport, Grand Bahama on September 27, 2017. This daytime ... , With oversight from the Ministry of Health’s National Stem Cell Ethics Committee (NSCEC) ...
Breaking Biology Technology:
Cached News: